US reforms could leave European biotech trailing, says Marks & Clerk report
This article was originally published in Scrip
Executive Summary
President Barack Obama's recent initiatives and reforms, particularly the lifting of the ban on federal funding of embryonic stem cell research, will strengthen the US biotechnology sector but leave the industry in Europe in danger of falling even further behind.